Two patients. Same disease. Same drug. Same dose.
One improves dramatically. The other develops severe side effects.
Why?
The answer may lie in their genes.
Pharmacogenomics — the study of how genetic variations affect drug response — is quietly transforming modern medicine. Variations in enzymes like CYP450 can determine whether a drug is metabolized too quickly (ineffective) or too slowly (toxic).
For example:
Some patients cannot properly metabolize clopidogrel.
Others may experience severe toxicity with standard doses of codeine.
Certain cancer therapies only work in patients with specific genetic mutations.
Yet in most clinical settings, medications are still prescribed using a “one-size-fits-all” approach.
Why This Matters ?
Adverse drug reactions are among the leading causes of hospitalizations worldwide. If genetic testing becomes routine:
Drug efficacy could improve
Side effects could decrease
Trial-and-error prescribing may reduce
Healthcare costs could drop
The Big Question
Should pharmacogenomic testing become mandatory before prescribing certain high-risk drugs?
As healthcare moves toward precision medicine, pharmacists may soon interpret genetic reports as often as they check drug interactions.
The future of prescribing may not begin with a prescription —
It may begin with a DNA report.
MBH/PS
